Degnan Chris
Chief Financial Officer
Sale
Calculated transaction value
$80.79K
2,202 shares @ $36.69
Traded
Oct 8, 2026
Filed
Oct 9, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UroGen Pharma Ltd
URGN
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
27 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Degnan Chris Chief Financial Officer | Oct 9, 2026 1-day lag | Sale Oct 8, 2026 | $80.79K Filed shares x price | SEC Form 4 View filing | |
| Degnan Chris Chief Financial Officer | Oct 9, 2026 1-day lag | Exercise Oct 8, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Degnan Chris Chief Financial Officer | Oct 9, 2026 1-day lag | Exercise Oct 8, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Sep 9, 2026 1-day lag | Sale Sep 8, 2026 | $37.38K Filed shares x price | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Sep 9, 2026 2-day lag | Exercise Sep 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Sep 9, 2026 2-day lag | Exercise Sep 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Smith Jason Drew General Counsel | Sep 9, 2026 1-day lag | Sale Sep 8, 2026 | $64.62K Filed shares x price | SEC Form 4 View filing | |
| Smith Jason Drew General Counsel | Sep 9, 2026 2-day lag | Exercise Sep 7, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Smith Jason Drew General Counsel | Sep 9, 2026 2-day lag | Exercise Sep 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Robinson James A. Jr. Director | Aug 28, 2026 2-day lag | Exercise Aug 26, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Robinson James A. Jr. Director | Aug 28, 2026 2-day lag | Exercise Aug 26, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Aug 24, 2026 4-day lag | Sale Aug 20, 2026 | $2.85M Filed shares x price | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Jul 10, 2026 1-day lag | Sale Jul 9, 2026 | $400K Filed shares x price | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Jun 24, 2026 2-day lag | Sale Jun 22, 2026 | $350.1K Filed shares x price | SEC Form 4 View filing | |
| Holden Stuart Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Robinson James A. Jr. Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Butitta Cynthia M Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Wildman Daniel George Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Robinson James A. Jr. Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Butitta Cynthia M Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Belldegrun Arie Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Wildman Daniel George Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Wen Leana Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Wen Leana Director | Jun 24, 2026 2-day lag | Award Jun 22, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Jun 9, 2026 1-day lag | Exercise Jun 8, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Jun 9, 2026 1-day lag | Sale Jun 8, 2026 | $142.56K Filed shares x price | SEC Form 4 View filing | |
| Schoenberg Mark Chief Medical Officer | Jun 9, 2026 1-day lag | Exercise Jun 8, 2026 | $0 Filed shares x price | SEC Form 4 View filing |
Degnan Chris
Chief Financial Officer
Exercise
Reported value range
Not reported
4,483 shares
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Degnan Chris
Chief Financial Officer
Exercise
Calculated transaction value
$0
4,483 shares @ $0
Traded
Oct 8, 2026
Filed
Oct 9, 2026
Schoenberg Mark
Chief Medical Officer
Sale
Calculated transaction value
$37.38K
871 shares @ $42.92
Traded
Sep 8, 2026
Filed
Sep 9, 2026
Schoenberg Mark
Chief Medical Officer
Exercise
Reported value range
Not reported
1,667 shares
Traded
Sep 7, 2026
Filed
Sep 9, 2026
Schoenberg Mark
Chief Medical Officer
Exercise
Calculated transaction value
$0
1,667 shares @ $0
Traded
Sep 7, 2026
Filed
Sep 9, 2026
Smith Jason Drew
General Counsel
Sale
Calculated transaction value
$64.62K
1,519 shares @ $42.54
Traded
Sep 8, 2026
Filed
Sep 9, 2026
Smith Jason Drew
General Counsel
Exercise
Reported value range
Not reported
3,334 shares
Traded
Sep 7, 2026
Filed
Sep 9, 2026
Smith Jason Drew
General Counsel
Exercise
Calculated transaction value
$0
3,334 shares @ $0
Traded
Sep 7, 2026
Filed
Sep 9, 2026
Robinson James A. Jr.
Director
Exercise
Reported value range
Not reported
2,000 shares
Traded
Aug 26, 2026
Filed
Aug 28, 2026
Robinson James A. Jr.
Director
Exercise
Calculated transaction value
$0
2,000 shares @ $0
Traded
Aug 26, 2026
Filed
Aug 28, 2026
Schoenberg Mark
Chief Medical Officer
Sale
Calculated transaction value
$2.85M
60,677 shares @ $47.05
Traded
Aug 20, 2026
Filed
Aug 24, 2026
Schoenberg Mark
Chief Medical Officer
Sale
Calculated transaction value
$400K
10,000 shares @ $40
Traded
Jul 9, 2026
Filed
Jul 10, 2026
Schoenberg Mark
Chief Medical Officer
Sale
Calculated transaction value
$350.1K
10,000 shares @ $35.01
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Holden Stuart
Director
Award
Calculated transaction value
$0
20,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Robinson James A. Jr.
Director
Award
Calculated transaction value
$0
10,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Butitta Cynthia M
Director
Award
Calculated transaction value
$0
8,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Wildman Daniel George
Director
Award
Calculated transaction value
$0
8,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Robinson James A. Jr.
Director
Award
Calculated transaction value
$0
8,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Butitta Cynthia M
Director
Award
Calculated transaction value
$0
10,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Belldegrun Arie
Director
Award
Calculated transaction value
$0
20,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Wildman Daniel George
Director
Award
Calculated transaction value
$0
10,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Wen Leana
Director
Award
Calculated transaction value
$0
8,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Wen Leana
Director
Award
Calculated transaction value
$0
10,000 shares @ $0
Traded
Jun 22, 2026
Filed
Jun 24, 2026
Schoenberg Mark
Chief Medical Officer
Exercise
Reported value range
Not reported
10,000 shares
Traded
Jun 8, 2026
Filed
Jun 9, 2026
Schoenberg Mark
Chief Medical Officer
Sale
Calculated transaction value
$142.56K
5,222 shares @ $27.3
Traded
Jun 8, 2026
Filed
Jun 9, 2026
Schoenberg Mark
Chief Medical Officer
Exercise
Calculated transaction value
$0
10,000 shares @ $0
Traded
Jun 8, 2026
Filed
Jun 9, 2026